Member Info for Topprize

Andy, hence why we have questioned what he has posted! This is a public forum where what you post whether you are predicting or think you are stating facts can be questioned. Have a good weekend all!

*stating

Agree with lordsutch he is not predicting he is staying that he has inside knowledge… prime example he said he was buying more and will be a TR1 no large trades to talk about the next day and no TRI. Seems Jimmy has a fan club.

Ian he says he know more than others doesn’t mean he does!! Last year he was stating the £400 million deal will be next week… Bla Bla Bla! Pinch of salt… first off he was saying he belonged to a group of investors in the know… story changes all the time!! Would
Love him to be right!! If he got one snippet right would be good but he hasn’t… if there was a TR1 when he said there would have been or even large trades to indicate he had bought more but there wasn’t!! All he says is F off to anyone who questions what he says!! Nothing he has stated has come to fruition!!

Where is your TR1 Jimmy not seen any big buys that you promised??

Especially when he tells us he has reported his own posts lol

Yes that was Jimmy and the £400 million pound deal with Croda.

Jimmy you talk utter rubbish!! You said it was going to drop today!! Then said you reckon the rise is as a result of you. You said all big investors left also you said you were going to leave this msg board!! Delusional!!

I still have trust in JN plus still believe SGS investment will come good. Think it’s been a pig of a couple of years for all stocks and shares. This will come good just a case of when… the fact the have invested in Igraine has boosted my confidence.. not worried that it has gone down… everything jumping about at the moment. May do a cheeky little top up on Monday gla

Bye x

Ian no need to apologise… Jimmy has been ‘calling it’ for months as in ‘this time next week’ It will be coincidental if commercialisation happens next week… we will all be happy but certainly won’t be thanking Jimmy and his mates down the pub!! The so called £400 million deal was supposed to happen months ago according to Jimmy!

Excellent still a way to go but this is progress. Gla

Ingraine have shares in Excalibur perhaps Vela couldn’t get a position there… so Excalibur have the rights to azd1656. So effectively yes we now have a stake in what they are doing.

Nice!

Jimmy you change yr tune like the wind… before Xmas you were telling everyone there is a deal for £400 million imminent.

Also this is your post 11 Jan so please don’t tell us real investors we don’t know how things work and you do!!

RE: Email11 Jan 2022 20:08
here is a straight question, can you and James Nomand give a straight answer,

have we been conned with our investment in the arcadia trial?

my self and a lot of other p i 's are over 65% down on our investment,

do you not think its time to ask questions regarding our 2.5 million investments?

in the agm, you recommend we vote to keep you, ( b f ) on the board, why?

please explain why? our share price is on its backside, and not looking to recover soon, so why?

i doubt you will answer this question,

if not, it will just make my mind up to vote for you, (brent) to not be re elected on the board, along with a lot of others,

i shall share this with the forums i use , and your response, if any, good or bad,

sgsc, and professor evans need to be asked questions,

Nice rise hopefully this will continue and get back to it’s starting price… at the very least

I agree I don’t think JN would have suspected this would take as long as it is. SGS is suppose to accelerate new treatments etc… which it has… seems we are stalled at the commercialisation. Given the rise in covid numbers around the globe you would think this would be needed. A new strain of Covid could arrive at anytime and it will happen just a case of when. People will be desperate for this treatment.

Dave Tapolczay, CEO of SGS said "We are delighted with the progress of the ARCADIA trial. Obviously the news that we will shortly have vaccines available is very welcome, but it doesn't remove the need for treatments for COVID-19, especially for those with underlying conditions such as diabetes. In some cases, the vaccines will not be suitable for people with those conditions, in other cases the vaccine may not be 100% effective. Add to this the fact that uptake and supply of the vaccine may not be optimal, and it is highly likely that treatments will be needed for many years to come. Nobody should assume there will be only one way out of this pandemic. Certainly, big pharma companies want to offer a full suite of products for any disease area whether vaccine, prophylaxis, therapeutic, and for recovery. Unlike many other treatments AZD1656 is not virus specific, as it is activating cells within our own body. This gives the treatment an advantage over many other treatments, and potentially it could be used in other virally induced respiratory diseases including other mutations of coronavirus, MERS and pneumonia. This gives AZD1656 longevity as a treatment beyond the current pandemic. AZD1656 is an orally available tablet that is stable at room temperature, making it suitable for use around the world. Furthermore, should the trial be successful, we expect to agree a commercial deal with a partner almost immediately."

Also JN has a shed load of Vela cash in the bank… no doubt looking at other investments we would hope…

Prefer a quiet day where little trades has no affect on the sp… happy to stay like this until news. Gla